NNelo Trade
← Back to Market News
November 04, 2026 at 12:08 PM UTC

MoonLake Immunotherapeutics reports financial results in SEC 8-K

MoonLake Immunotherapeutics filed an 8-K covering results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: November 04, 2026 at 12:07 PM UTC

Open official source
MoonLake Immunotherapeutics reports financial results in SEC 8-K | Nelo Trade